Safety Alerts and Products Recalls > Medicine recalls

Medicine recalls   The United States: Enforcement Report: Recall of Helix Pain Relieving Cream, Helix Tri-Active Therapy Cream, Helix CBD Therapy Cream and Helix CBD Clinical Cream   The US Food and Drug Administration (FDA) announces that Parker Laboratories, Inc. is recalling the following products due to CGMP deviations: - Helix Pain Relieving Cream (menthol 7.4%) (lot number: J0721010, J1022017, A0521002, A0322006, A0323004, A0422005, A0521001, A0822004, C0222001, C0521003, C0822005, C0721019, C0521001, C0721022, C0822006, C0323006, C0821022, C0922006, C1221003) - Helix Tri-Active Therapy Cream (camphor 3.2%, menthol 7.4%, methyl salicylate 12.5%) (lot number: A1221010, A1221011) - Helix CBD Therapy Cream (menthol 7.4%) (lot number: J1121010, A0921006, A0921007) - Helix CBD Clinical Cream (menthol 7.4%) (lot number: J1121011, A0921009, A0921008) Please refer to the following website in FDA for details: http://www.accessdata.fda.gov/../index.cfm?Product=202591 http://www.accessdata.fda.gov/../index.cfm?Product=202592 http://www.accessdata.fda.gov/../index.cfm?Product=202593 http://www.accessdata.fda.gov/../index.cfm?Product=202594 In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product manufactured by Parker Laboratories, Inc. Ends/Wednesday, Aug 30, 2023 Issued at HKT 16:00